Embera Management Team
- Robert B. Linke
- Carol A. Gloff, Ph.D.
- Douglas Feltner, M.D.
- Barbara Fox, Ph.D.
- Nicholas Goeders, Ph.D.
- Michael Short
Embera Board of Directors
Scientific Advisory Board
- George Koob, Ph.D.
- Charles O'Brien, MD, Ph.D.
- Bruce McCarthy, MD
- Kathleen Brady, MD, Ph.D.
- Rajita Sinha, Ph.D.
Investors
Douglas Feltner, M.D.
Dr. Feltner leads Embera’s clinical research and development on a consulting basis. He has more than 13 years of experience in pharmaceutical drug development and translational medicine, including positions with Solvay, Warner Lambert and Pfizer, where he was most recently Vice President, Global Head of Translational Medicine. Prior to that he worked on Lyrica® and Chantix®. He has over 40 peer-reviewed scientific publications. Dr. Feltner is a board certified psychiatrist having received his M.D. degree with distinction in research at the University of Michigan as well as a B.S. in Biology (honors) and B.A. in English from the University of Michigan.